Publication | Open Access

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

VaccinationVaccine SafetyVaccinologyVaccine TrialPlacebo-controlled Clinical TrialsVaccine EfficacyPreliminary Aggregate SafetyMedicineVaccine ResearchPhase 1